Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism 5-HT1B receptor antagonists(Serotonin 1b (5-HT1b) receptor antagonists), Monoamine reuptake inhibitor |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alcohol Use Disorder | Preclinical | United States | 01 Jun 2025 | |
| Anorexia | Preclinical | United States | 01 Jun 2025 | |
| Binge-Eating Disorder | Preclinical | United States | 01 Jun 2025 |





